Willows Veterinary Centre and Referral Service, Highlands Road, Solihull, West Midlands B90 4NH, UK.
Laboratório de Farmacologia e Neurobiologia, Centro de Investigação Farmacológica e Inovação Medicamentosa (MedInUP), Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto (ICBAS-UP), Porto, Portugal.
Vet J. 2020 Nov;265:105549. doi: 10.1016/j.tvjl.2020.105549. Epub 2020 Sep 24.
Atrial fibrillation (AF) is the most common non-physiological arrhythmia in dogs and humans. Its high prevalence in both species and the impact it has on survival time and quality of life of affected patients, makes it a very relevant topic for medical research. In dogs, the diagnosis of AF is usually fairly straightforward, but optimal management can be complicated. Rate control is the most commonly used strategy; rhythm control can also be considered in very specific cases. Concurrent congestive heart failure is frequently identified, which represents an extra challenge for the clinicians. This article reviews the current recommendations for the diagnosis and management considerations of AF in dogs. Future perspectives, focusing on new drugs that may prevent development of AF based on recent discoveries, will also be discussed.
心房颤动（AF）是犬和人类中最常见的非生理性心律失常。它在这两个物种中的高患病率以及对受影响患者的生存时间和生活质量的影响，使其成为医学研究中一个非常相关的课题。在犬中，AF 的诊断通常相当直接，但最佳管理可能会很复杂。控制心率是最常用的策略；在非常特定的情况下也可以考虑控制节律。通常会同时发现充血性心力衰竭，这对临床医生来说是一个额外的挑战。本文回顾了犬心房颤动的诊断和管理注意事项的现行建议。还将讨论未来的展望，重点是基于最近的发现可能预防 AF 发展的新药。
